Publication | Closed Access
Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial
139
Citations
21
References
2010
Year
In this study, denosumab was well tolerated and effective through 6 yr of continuous treatment in postmenopausal women with low bone mass.
| Year | Citations | |
|---|---|---|
Page 1
Page 1